Zenatech publishes MD&A for three months ended March 31, 2026

Zenatech published an amended MD&A for the three months ended March 31, 2026.

The amendment adds clarity on company loans disclosed in long-term debt, equity, and share issuance discussions within the operations section.

The financial statements were not revised, and no other MD&A disclosures were changed.

The report flags reliance on internally generated cash flow, private debt or equity placements, and revolving related-party credit lines to fund operations.

Continuation depends on future profitability, customer growth, and execution of a financing plan for ongoing operations.